Olmesartan associated enteropathy. A multiface clinical and histological entity

Dig Liver Dis. 2021 May;53(5):666-668. doi: 10.1016/j.dld.2021.02.024. Epub 2021 Mar 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Colonic Diseases / chemically induced*
  • Colonic Diseases / pathology
  • Diarrhea / chemically induced
  • Humans
  • Hypertension / drug therapy
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Male
  • Tetrazoles / administration & dosage
  • Tetrazoles / adverse effects*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Tetrazoles
  • olmesartan